“Liposomal” means a formula is designed around tiny lipid vesicles called liposomes. A liposome has a water-containing interior surrounded by one or more phospholipid membranes. Depending on the ingredient, a compound may sit in that watery space or associate with the lipid membrane. This delivery design lets formulators place ingredients in a watery core or alongside a lipid membrane. Human studies then test how the specific formulation changes exposure and outcomes.
The word has become shorthand for “advanced,” which sounds excellent on a label. Size, loading, stability, and digestion matter. Human evidence is formula-specific. Here is how to judge the claim.
The short answer
- A liposome is a small vesicle with a phospholipid membrane and a watery interior.
- “Liposomal” does not reveal how much of the active ingredient is actually encapsulated or how stable the formula is.
- Some named liposomal vitamin C formulas produced higher short-term blood exposure than matched non-liposomal vitamin C in small human studies.
- Higher exposure is not the same as a proven clinical benefit, and one formula's data cannot certify every product.
- Look for ingredient amount, phospholipid source, formulation testing, and a human comparison using the exact product.
What is a liposome?
Phospholipids have one part that interacts readily with water and another that prefers lipids. In water they can arrange into a two-layer membrane, with water-facing parts on the outside and inside and lipid-loving parts facing each other. Close that membrane into a little sphere and you have a liposome. The central compartment can hold water-soluble material; the membrane can incorporate some fat-soluble material. Depending on the design, there may be one membrane or several concentric layers. A technical review of liposome structure describes these configurations.
A simplified liposome
The vesicle sits in a liquid formulation.
A lipid bilayer forms the boundary.
Some water-soluble ingredients may be enclosed here.
This is a structural sketch, not proof that every molecule in a finished supplement is encapsulated or reaches a particular tissue.
A finished product may also contain active ingredient outside the vesicles. Encapsulation efficiency is the fraction of ingredient initially used that ends up associated with vesicles; loading capacity describes the incorporated amount relative to lipid or carrier mass. These are different measurements. Both vary with the ingredient, lipid recipe, and process. A liposomal label alone tells you neither number. “Liposomal vitamin C” is still vitamin C presented in a particular formulation.
How are liposomal supplements made?
There is no single universal recipe. Broadly, manufacturers combine phospholipids with the ingredient and water to form vesicles, then may use methods such as mixing, homogenization, sonication, or extrusion to change particle size and distribution. They can adjust lipid composition, concentration, pH, and other factors to influence stability. The resulting material needs testing: particle size, size distribution, amount of active ingredient, fraction encapsulated, and how those properties change during storage. Reviews of oral liposome formulation describe the technical tradeoffs.
Do not assume every brand uses the same method, phospholipid, or particle size. For products in the Infinite Labs Liposomal collection, use the current label for ingredient amounts, phospholipid sources and storage directions. Precise manufacturing or encapsulation claims require supporting formulation records. If a company makes a precise “nano-sized” or “90% encapsulated” claim, it should be able to show the test method, batch context, and stability data behind that number.
What happens after you swallow a liposome?
The digestive tract is not a clear glass tube through which a perfect sphere floats unchanged into a cell. Stomach conditions, bile, digestive enzymes, dilution, and the intestinal barrier can alter or break up vesicles. The active ingredient may be released, transported differently, or mixed into other lipid structures during digestion. A review of oral delivery challenges notes gastrointestinal instability and difficulty crossing biological membranes as central problems to solve.
Formulation-specific human studies help determine how an oral liposomal design performs through these digestive conditions. An electron-microscope picture before swallowing can confirm structure in a sample. It cannot tell us what a person's blood levels or health outcomes will be afterward. Likewise, claims that liposomes “bypass digestion” or automatically “fuse with every cell” turn a research question into a cartoon.
Do liposomal supplements absorb better?
Sometimes a studied formulation increases a short-term exposure measure. That is a defensible answer. A blanket answer for every nutrient and every bottle is not. Researchers commonly compare peak blood concentration (Cmax) and area under the concentration-time curve (AUC) after equal doses. Those measurements help describe exposure; they are not the same thing as symptom relief, improved function, or disease prevention.
| Study | Result | Limit |
|---|---|---|
| Purpura et al., 2024 | 27 adults, randomized crossover; one 500 mg named liposomal vitamin C formula versus 500 mg regular C and placebo. Plasma peak +27% and 24-hour AUC +21% versus regular C; leukocyte peak +20% and AUC +8%. | One dose, one formula, 24-hour exposure; no health-outcome test and not an Infinite Labs product. |
| Sinha et al., 2018 | 12 adults took 500 or 1,000 mg/day liposomal glutathione for four weeks; several glutathione and other biomarkers rose from baseline. | Small pilot without a placebo or non-liposomal comparison; cannot establish relative absorption or clinical benefit. |
| Carr review, 2025 | Nine of ten liposomal-vitamin-C studies found higher measured exposure than comparison C, across varied formulas. | Doses ranged 0.15–10 g and sampling 4–24 hours; little evidence on elimination, cellular uptake, or biological outcomes. |
The 2024 vitamin C trial is a useful example of a fairer test: it compared equal vitamin C doses and measured both plasma and white-blood-cell concentrations. Yet it studied LipoVantage, a named formulation, and did not measure whether participants felt better or avoided illness. We cannot apply its +27% peak result to Infinite Labs Liposomal Vitamin C+ or to magnesium or glutathione. If a site quotes the number without naming the actual tested formula, a key part of the evidence has gone missing.
The glutathione pilot answers a different question: what happened during four weeks of one liposomal glutathione intervention. Without placebo or standard-glutathione arms, it cannot tell us what change would have occurred otherwise or whether the liposome outperformed another format. And because none of these trials used Infinite Labs Liposomal Glutathione+, we do not present them as proof for our bottle.
Does higher blood exposure mean a better health result?
Not automatically. Blood concentrations can be a useful intermediate measurement, but the relationship between exposure and a meaningful outcome depends on the ingredient, baseline nutritional status, dose, tissue, and endpoint. For an essential vitamin, someone already consuming enough may not gain a practical benefit from a higher short-term peak. For another ingredient, an increased AUC might be relevant—but the clinical result still needs testing. “More in blood” is a finding; “better for you” is an additional claim.
The 2025 review of ten liposomal-vitamin-C studies illustrates both sides. Nine reported higher bioavailability measures, but formulations, doses, and sampling periods differed greatly. None assessed urinary elimination, only two measured cellular uptake in vivo, and only two assessed potential biological effects. The review supports continued research, not a universal percentage increase to print on every liposomal label.
Is liposomal the same as a micelle or an oil capsule?
No. These are related ideas in lipid-based delivery, but the structures differ. A classic liposome has a phospholipid bilayer surrounding an aqueous compartment. A micelle generally has a different, single-layer arrangement; an oil-filled softgel is another format. A liquid containing phospholipids does not automatically demonstrate that stable, ingredient-loaded liposomes are present through shelf life. Names on front labels can be broad, so a technically specific claim deserves technically specific evidence.
Nor does “liposomal” tell you whether a product is liquid, capsule, or powder. Those are serving formats. The delivery structure, if present, must be characterized for the formulation as sold and stored. Ease of use, taste, allergens, and serving size may be more important to your daily choice than a theoretical particle diagram.
How can you judge a liposomal product?
- Start with the active ingredient and amount. Read the Supplement Facts quantity per serving. Delivery language does not replace the dose.
- Inspect the phospholipid source and other ingredients. Soy, sunflower, capsule materials, sweeteners, and flavorings may matter for preferences or allergies.
- Ask what was measured. Particle size, encapsulation efficiency, and stability are different checks. A photo alone is not a clinical trial.
- Match the study to the product. Same ingredient, dose, finished formula, comparator, population, and relevant outcome? If not, treat the result as background research.
- Check storage and use directions. A well-designed formula still needs to retain its properties over its stated shelf life.
The Liposomal collection includes formats such as Glutathione+, Vitamin C+, and Magnesium+. Each product needs its own label and evidence review. The fact that one named vitamin C formula changed short-term exposure does not tell us how another nutrient or another manufacturer's formula performs. Compare each option by the nutrient you want, its serving format and current directions, then review any supporting study for the exact formula.
Frequently asked questions
What does “liposomal” mean on a supplement label?
It indicates a lipid-vesicle delivery concept. The label alone does not disclose actual encapsulation efficiency, particle stability, or human performance.
Are liposomal vitamins always better absorbed?
No universal rule has been established. Some particular liposomal vitamin C formulas showed higher short-term exposure in small human studies. Results cannot be transferred to every vitamin or product.
Do liposomes bypass the stomach?
No. Oral formulations encounter digestion, bile, enzymes, and intestinal barriers. Stability through those conditions is a formulation-specific research question.
Is a higher plasma level a health benefit?
It is an exposure measurement. A health benefit requires a relevant endpoint in people and a study design able to attribute the result to the tested product.
Can I tell whether a product is truly liposomal by looking at it?
No. Appearance, cloudiness, or taste do not measure liposome structure or ingredient loading. Ask for appropriate characterization and stability data.
The practical takeaway
Liposomal is a meaningful formulation idea: a phospholipid vesicle can carry an ingredient in or alongside its membrane. Whether that idea improves an oral supplement depends on execution and evidence. Check what was actually made, what survived storage and digestion, and what a human study measured. The word on the front label is the beginning of the question, not the answer.
Sources
- Liposome classification, structure, and preparation review.
- Adapting liposomes for oral delivery: barriers and formulation review.
- Encapsulation efficiency and loading capacity review.
- Purpura et al. Liposomal vitamin C randomized crossover trial, 2024.
- Sinha et al. Oral liposomal glutathione pilot, 2018.
- Carr. Liposomal vitamin C bioavailability scoping review, 2025.
Educational information, not medical advice. Infinite Labs supplements are not intended to diagnose, treat, cure, or prevent any disease.
Keep it useful
Join the conversation